Cite
HARVARD Citation
Lo Re, M. et al. (2015). Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers. Neurology and therapy. 4 (2), pp. 147-157. [Online].